(Q24318854)

Apolipoprotein B mRNA editing enzyme catalytic subunit 3F

GOA release 2020-03-11

1 reference

negative regulation of viral process

GOA release 2020-03-11

1 reference

Journal of Biological Chemistry

GOA release 2020-03-11

0 references

Michael H Malim

4

0 references

author name string

Rebecca K Holmes

series ordinal

1

0 references

Fransje A Koning

series ordinal

2

0 references

Kate N Bishop

series ordinal

3

0 references

language of work or name

English

0 references

publication date

26 January 2007

0 references

published in

0 references

volume

282

0 references

page(s)

2587-95

0 references

issue

4

0 references

cites work

G to A hypermutation of hepatitis B virus.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

APOBEC-mediated interference with hepadnavirus production

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Cytidine deaminase. The 2.3 A crystal structure of an enzyme: transition-state analog complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

APOBEC3F properties and hypermutation preferences indicate activity against HIV-1 in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Cytidine deamination of retroviral DNA by diverse APOBEC proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Complementary function of the two catalytic domains of APOBEC3G.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

DNA deamination mediates innate immunity to retroviral infection

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

The Protein Network of HIV Budding

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

HIV-1 Vif Blocks the Antiviral Activity of APOBEC3G by Impairing Both Its Translation and Intracellular Stability

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

DNA deamination: not just a trigger for antibody diversification but also a mechanism for defense against retroviruses

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

G-->A hypermutation of the human immunodeficiency virus type 1 genome: evidence for dCTP pool imbalance during reverse transcription

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

APOBEC3 proteins inhibit human LINE-1 retrotransposition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Regulated production and anti-HIV type 1 activities of cytidine deaminases APOBEC3B, 3F, and 3G

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Inhibition of hepatitis B virus replication by APOBEC3G.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Antiviral potency of APOBEC proteins does not correlate with cytidine deamination

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021

Role and mechanism of action of the APOBEC3 family of antiretroviral resistance factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M607298200

7 January 2021